| French regulator says women taking the drug were four times more likely to have babies with malformations Related items from OnMedica New guidelines on epilepsy in pregnancy Study reveals mental cost of epilepsy in pregnancy Tougher restrictions on valproates Antidepressant linked to increased risk of birth defects Antidepressants in pregnancy linked to heightened risk of birth defects |
Friday 21 April 2017
Epilepsy drug linked to 4,000 birth defects in France
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment